首页 | 官方网站   微博 | 高级检索  
     


Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
Affiliation:1. Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, USA;2. Harvard Medical School, Boston, USA;3. Department of Medicine, Georgetown University, Washington, USA;4. Department of Medicine, University of California San Francisco, San Francisco, USA;5. Department of Medicine, University of California, Irvine, USA;6. Division of Medical Oncology, National Cancer Centre Singapore, Singapore;7. Department of Pathology, Massachusetts General Hospital, Boston, USA
Abstract:
Keywords:RET  non-small-cell lung cancer  resistance  tyrosine kinase inhibitor  pralsetinib  selpercatinib
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号